Bruton's tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib
about
Targeted Therapies in Adult B-Cell MalignanciesTargets for Ibrutinib Beyond B Cell MalignanciesThe splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia.Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cellsHM71224, a novel Bruton's tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritisTargeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances.Ibrutinib: from bench side to clinical implications.Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells.Investigational Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application.
P2860
Q26783195-B346A0E2-2D46-4C3F-BD8D-0547237C65C2Q28087772-9BF25995-981F-4417-882C-A5EF685B54B7Q30395427-5F044FE3-6454-4BB1-8895-FD332688AC07Q36777093-CF2471BE-E279-4EF0-9567-1F08EA96685FQ36810546-5F8F9538-FBD0-4863-AD08-885E78BCEF3BQ38554422-7E839BFF-1B07-401C-A03D-F3CC008E3F0DQ38557067-6025B0D4-5988-46DB-8458-4AF8C6C82822Q38668222-BDF7FFC2-C0DC-4A86-8844-AF70D64D75ECQ38826405-22E28D23-30CD-4EFF-A17B-ABFDE9755F3DQ42204673-6580F910-4E5E-4A00-BABD-C539603B7829
P2860
Bruton's tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Bruton's tyrosine kinase inhib ...... lignancies: focus on ibrutinib
@ast
Bruton's tyrosine kinase inhib ...... lignancies: focus on ibrutinib
@en
Bruton's tyrosine kinase inhib ...... lignancies: focus on ibrutinib
@nl
type
label
Bruton's tyrosine kinase inhib ...... lignancies: focus on ibrutinib
@ast
Bruton's tyrosine kinase inhib ...... lignancies: focus on ibrutinib
@en
Bruton's tyrosine kinase inhib ...... lignancies: focus on ibrutinib
@nl
prefLabel
Bruton's tyrosine kinase inhib ...... lignancies: focus on ibrutinib
@ast
Bruton's tyrosine kinase inhib ...... lignancies: focus on ibrutinib
@en
Bruton's tyrosine kinase inhib ...... lignancies: focus on ibrutinib
@nl
P2860
P356
P1476
Bruton's tyrosine kinase inhib ...... lignancies: focus on ibrutinib
@en
P2093
A. Aalipour
R. H. Advani
P2860
P304
P356
10.1177/2040620714539906
P407
P577
2014-08-01T00:00:00Z